450 results
·
25ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Test, Factor V Leiden Mutations, Genomic Dna Pcr
FDA classification
FDA Class 2
·Test, Factor V Leiden Mutations, Genomic Dna Pcr
Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
FDA classification
FDA Class 2
·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
FDA classification
FDA Class 2
·Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr
Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set
FDA classification
FDA Class 2
·Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set
Cardiac Allograft Gene Expression Profiling Test System
FDA classification
FDA Class 2
·Cardiac Allograft Gene Expression Profiling Test System
Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
FDA classification
FDA Class 2
·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
Dna Genetic Analyzer
FDA classification
FDA Class 2
·Dna Genetic Analyzer
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
FDA classification
FDA Class 2
·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings